Revolution Medicines (RVMD) EBITDA Margin Growth (1y) (2020 - 2023)
Revolution Medicines (RVMD) EBITDA Margin Growth (1y) (2020 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 1,997.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2.39 Mn |
| Jun 30, 2023 | -216,401.00 |
| Mar 31, 2023 | -30,683.00 |
| Dec 31, 2022 | 15,681.00 |
| Sep 30, 2022 | 254,813.00 |
| Jun 30, 2022 | -16,908.00 |
| Mar 31, 2022 | -39,557.00 |
| Dec 31, 2021 | -16,989.00 |
| Sep 30, 2021 | -461,101.00 |
| Jun 30, 2021 | -23,287.00 |
| Mar 31, 2021 | -18,654.00 |
| Dec 31, 2020 | -22,759.00 |
| Sep 30, 2020 | -10,919.00 |
| Jun 30, 2020 | -19,315.00 |
| Mar 31, 2020 | -10,333.00 |